|
Volumn 58, Issue 11, 2014, Pages 1571-1576
|
Antibacterial Resistance Leadership Group: Open for business
|
Author keywords
Antibacterial resistance; ARLG; Clinical research; Clinical trials; Leadership Group
|
Indexed keywords
ANTIBIOTIC RESISTANCE;
ARTICLE;
CLINICAL RESEARCH;
GRAM NEGATIVE INFECTION;
GRAM POSITIVE INFECTION;
INFECTION PREVENTION;
LEADERSHIP;
MEDICAL PRACTICE;
PRIORITY JOURNAL;
BACTERIAL INFECTIONS;
DRUG UTILIZATION;
FINANCIAL MANAGEMENT;
HUMAN;
MEDICAL RESEARCH;
MICROBIOLOGY;
NATIONAL HEALTH ORGANIZATION;
STANDARDS;
TRENDS;
UNITED STATES;
ANTIINFECTIVE AGENT;
ANTI-BACTERIAL AGENTS;
BACTERIAL INFECTIONS;
BIOMEDICAL RESEARCH;
CAPITAL FINANCING;
DRUG RESISTANCE, BACTERIAL;
DRUG UTILIZATION;
HUMANS;
LEADERSHIP;
NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES (U.S.);
UNITED STATES;
|
EID: 84900456166
PISSN: 10584838
EISSN: 15376591
Source Type: Journal
DOI: 10.1093/cid/ciu132 Document Type: Article |
Times cited : (20)
|
References (0)
|